• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 5/16/24: World Courier President Talks Mitigating Supply Chain Risks, Walgreens Brand Naloxone Available Online and In Stores & more


The latest news for pharma industry insiders.

LogiPharma Europe 2024: World Courier President Talks Mitigating Supply Chain Risks

In an interview with Pharma Commerce Editor Nicholas Saraceno at LogiPharma Europe, Nick Porter, President, World Courier discusses mitigating supply chain risks, the future of artificial intelligence in pharma logistics, and more.

Study: Contact With Children Causes Transmission of Pneumococcal Disease Among Older Adults

The prevalence of transmission was higher for those who had contact with children aged less than 5 years and aged 5 to 9 years compared with children aged older than 10.

Senators Propose $32 Billion in Annual A.I. Spending but Defer Regulation

Their plan is the culmination of a yearlong listening tour on the dangers of the new technology.

Walgreens Brand Naloxone Available Online and In Stores This Month

Walgreens announced it is expanding access to an over the counter, life-saving medication with the launch of Walgreens Brand Naloxone HCI Nasal Spray. The product—which retails for $34.99, a lower price than the comparable national brand product at Walgreens stores, can reverse an overdose from opioids. The product is currently available online and will be chainwide in all stores by the end of the month, where it can be found in the pain aisle, providing a critical point of access for the nearly 10 million customers and patients the company serves every day in local communities throughout the U.S.

@SyneosHealth on Twitter/X:

This @PharmExec article explores the intricate landscape for mergers and acquisitions and strategic partnerships in today’s high-stakes environment. Learn more about biopharma innovation and our insights from the 2024 Dealmakers’ Intentions Survey: https://pharmexec.com/view/twists-turns-biopharma-dealmaking-2024-trends

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs